Clinical Trial Update: Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase IIa multicentre study of VR040 in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• VR040

Snippet

Sponsor: South Glasgow University Hospitals NHS Trust | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED